JP2002520286A5 - - Google Patents

Download PDF

Info

Publication number
JP2002520286A5
JP2002520286A5 JP2000558822A JP2000558822A JP2002520286A5 JP 2002520286 A5 JP2002520286 A5 JP 2002520286A5 JP 2000558822 A JP2000558822 A JP 2000558822A JP 2000558822 A JP2000558822 A JP 2000558822A JP 2002520286 A5 JP2002520286 A5 JP 2002520286A5
Authority
JP
Japan
Prior art keywords
composition
formula
caffeine
compound
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000558822A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002520286A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/013670 external-priority patent/WO2000002562A1/en
Publication of JP2002520286A publication Critical patent/JP2002520286A/ja
Publication of JP2002520286A5 publication Critical patent/JP2002520286A5/ja
Withdrawn legal-status Critical Current

Links

JP2000558822A 1998-07-09 1999-06-18 Gaba類縁体及びカフェインを含んでなる組成物 Withdrawn JP2002520286A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9213198P 1998-07-09 1998-07-09
US60/092,131 1998-07-09
PCT/US1999/013670 WO2000002562A1 (en) 1998-07-09 1999-06-18 Compositions comprising gaba analogs and caffeine

Publications (2)

Publication Number Publication Date
JP2002520286A JP2002520286A (ja) 2002-07-09
JP2002520286A5 true JP2002520286A5 (US07794700-20100914-C00152.png) 2006-08-10

Family

ID=22231777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000558822A Withdrawn JP2002520286A (ja) 1998-07-09 1999-06-18 Gaba類縁体及びカフェインを含んでなる組成物

Country Status (13)

Country Link
US (1) US6326374B1 (US07794700-20100914-C00152.png)
EP (1) EP1094817A1 (US07794700-20100914-C00152.png)
JP (1) JP2002520286A (US07794700-20100914-C00152.png)
KR (1) KR20010071777A (US07794700-20100914-C00152.png)
AU (1) AU772156B2 (US07794700-20100914-C00152.png)
BR (1) BR9911917A (US07794700-20100914-C00152.png)
CA (1) CA2332915C (US07794700-20100914-C00152.png)
ID (1) ID28277A (US07794700-20100914-C00152.png)
NO (1) NO20010119L (US07794700-20100914-C00152.png)
NZ (1) NZ508490A (US07794700-20100914-C00152.png)
PL (1) PL345340A1 (US07794700-20100914-C00152.png)
WO (1) WO2000002562A1 (US07794700-20100914-C00152.png)
ZA (1) ZA200007168B (US07794700-20100914-C00152.png)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003167A1 (en) 1996-07-24 1998-01-29 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
DK1169060T3 (da) * 1999-04-09 2006-01-16 Euro Celtique Sa Natriumkanalblokkerpræparater og anvendelse deraf
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
MXPA04002009A (es) 2001-09-03 2004-07-08 Newron Pharm Spa Composicion farmaceutica que comprende gabapentina o un analogo de la misma y alfa-aminoamida y su uso como analgesico.
ATE371496T1 (de) * 2004-03-12 2007-09-15 Warner Lambert Co C1-symmetrische bisphosphinliganden und deren verwendung bei der asymmetrischen synthese von pregabalin
JP2007530657A (ja) * 2004-04-01 2007-11-01 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Pキラル性ホスホランの調製および不斉合成でのその使用
DE602005018965D1 (de) * 2004-06-21 2010-03-04 Warner Lambert Co Herstellung von pregabalin und verwandten verbindungen
KR101277520B1 (ko) * 2004-09-10 2013-06-21 뉴론 파마슈티칼즈 에스. 피. 에이. (할로벤질옥시)벤질아미노-프로판아미드를 포함하는 선택적 나트륨 및/또는 칼슘 채널 조절제로서 유용한 약제학적 조성물
ES2556937T3 (es) 2005-12-22 2016-01-21 Newron Pharmaceuticals S.P.A. Derivados de 2-feniletilamino como moduladores de los canales de calcio y/o sodio
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
CH699327B1 (de) 2007-02-14 2010-03-15 Oerlikon Heberlein Temco Wattw Vorrichtung zum gleichzeitigen Behandeln von mehreren multifilen Fäden.
US10300031B2 (en) 2007-08-06 2019-05-28 Trinity Laboratories Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
JP2010043063A (ja) * 2008-05-09 2010-02-25 Agency For Science Technology & Research 川崎病の診断及び治療
US20100190752A1 (en) * 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
WO2012059797A1 (en) 2010-11-04 2012-05-10 Lupin Limited Process for synthesis of (s) - pregabalin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656177A (en) 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US5248678A (en) * 1992-06-30 1993-09-28 Fractal Laboratories, Inc. Methods for increasing arousal and alertness and for the amelioration of comatose states
AU7604194A (en) 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
US5443838A (en) 1993-09-15 1995-08-22 Koenig, Jr.; Steven M. Nutritional supplementation system
ES2167717T3 (es) 1996-03-14 2002-05-16 Warner Lambert Co Nuevos aminoacidos ciclicos sustituidos como agentes farmaceuticos.
AU4078897A (en) * 1996-08-23 1998-03-06 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
ATE361909T1 (de) * 1996-10-23 2007-06-15 Warner Lambert Co Substituierte gamma-aminobuttersäurederivate als arzneimittel
ATE311867T1 (de) * 1997-09-08 2005-12-15 Warner Lambert Co Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen

Similar Documents

Publication Publication Date Title
JP2002520286A5 (US07794700-20100914-C00152.png)
JP2001515033A5 (US07794700-20100914-C00152.png)
JP2003528918A5 (US07794700-20100914-C00152.png)
JP2002508352A5 (ja) 4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2001515859A5 (US07794700-20100914-C00152.png)
JP2002502874A5 (US07794700-20100914-C00152.png)
JP2002519425A5 (US07794700-20100914-C00152.png)
JP2002519434A5 (US07794700-20100914-C00152.png)
JP2002508362A5 (ja) 1−置換−1−アミノメチル−シクロアルカン誘導体(=ガバペンチン類縁体)
JP2003531118A5 (US07794700-20100914-C00152.png)
JP2002533472A5 (US07794700-20100914-C00152.png)
JP2001512743A5 (US07794700-20100914-C00152.png)
JP2002541233A5 (US07794700-20100914-C00152.png)
JP2002509153A5 (US07794700-20100914-C00152.png)
JP2002541198A5 (ja) 失禁治療用医薬組成物
JP2001526218A5 (US07794700-20100914-C00152.png)
JP2001520998A5 (US07794700-20100914-C00152.png)
JP2004530641A5 (US07794700-20100914-C00152.png)
JP2002531505A5 (US07794700-20100914-C00152.png)
JP2002536359A5 (US07794700-20100914-C00152.png)
CA2577740A1 (en) Method of enhancing absorptions of transmucosal administration formulations
JP2002508361A5 (US07794700-20100914-C00152.png)
JP2005510540A5 (US07794700-20100914-C00152.png)
JP2002527396A5 (US07794700-20100914-C00152.png)